Related Experiment Videos

Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor

F Ponchel1, A Puisieux, E Tabone

  • 1Laboratoire d'Oncologie Moléculaire, INSERM CJF9302, Lyon, France.

Cancer Research
|April 15, 1994
PubMed

Insights

Mutant p53 proteins can alter cell survival and division but do not fully transform cancer cells. This is due to transforming growth factor beta 1-induced apoptosis, which is unaffected by mutant p53.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Mutations in the p53 gene disrupt its tumor suppressor function.
  • The potential for mutant p53 proteins to possess intrinsic transforming abilities and their mechanisms of action remain largely unknown.

Purpose of the Study:

  • To investigate whether a specific p53 mutation (p53-249ser) confers transforming ability to p53-deficient hepatoma cells.
  • To explore the underlying mechanisms of any observed phenotypic changes.

Main Methods:

  • Transfection of p53-deficient hepatoma cells (Hep3B) with the mutant p53-249ser.
  • Assessment of in vitro survival, mitotic activity, and tumorigenic potential.
  • Evaluation of the role of transforming growth factor beta 1 (TGF-β1) in apoptosis.

Main Results:

  • Hep3B cells expressing p53-249ser exhibited increased in vitro survival and mitotic activity.
  • The expression of p53-249ser did not significantly enhance the tumorigenic potential of these cells.
  • TGF-β1-mediated apoptosis in Hep3B cells remained unaffected by the presence of mutant p53-249ser.

Conclusions:

  • While mutant p53 can influence cellular proliferation, it does not confer full transforming ability in this context.
  • TGF-β1-induced apoptosis acts as a barrier to the oncogenic potential of mutant p53 in these hepatoma cells.

Related Concept Videos